13-valent pneumococcal polysaccharide conjugate vaccine (PCV13i) / Sinovac, CanSino 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
13-valent pneumococcal polysaccharide conjugate vaccine (PCV13i) / Sinovac, CanSino
NCT04841369: Phase III Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above (PICTPCV13i)

Recruiting
3
3420
RoW
13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(CRM197,TT), PCV13i, 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine, Prevnar
CanSino Biologics Inc., Henan Center for Disease Control and Prevention
Pneumococcal Infections, Streptococcal Infections, Bacterial Infections
08/22
04/23
PICTON, NCT04100772: Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above

Active, not recruiting
1
237
RoW
13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(CRM197,TT), 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
CanSino Biologics Inc., Henan Center for Disease Control and Prevention
Pneumococcal Infections, Streptococcal Infections, Bacterial Infections
09/21
12/21
NCT05092386: Safety and Immunogenicity Study of a 13-valent Pneumococcal Polysaccharide Conjugate Vaccine

Not yet recruiting
1
310
RoW
Investigational 13-valent Pneumococcal Polysaccharide Conjugate Vaccine, Control 13-valent Pneumococcal Polysaccharide Conjugate Vaccine ( WALVAX PCV13), Control 13-valent Pneumococcal Polysaccharide Conjugate Vaccine ( Pfizer PCV13)
Sinovac Research and Development Co., Ltd.
Pneumococcal Infections
01/22
12/23

Download Options